DIPPER Study: RCT Evaluating a Novel Force-Activated Separation
[Sponsored] While over 90% of inpatient admits in the US have a peripheral intravenous catheter (PIV) inserted, the rate of failure has been reported between 36% and 63%1, which can lead to significant delays in therapy and more importantly, costly IV restarts. These PIV failures are largely the result of mechanical complications. This randomized controlled trial evaluates a novel Force-Activated Separation Device (FASD) to determine its impact on PIV complication rates and delays in infusion therapy.
Download white paper to learn more
Sponsored By
ÍÃ×ÓÏÈÉúdoes not support or endorse connections products or services.
Fill out my .
Related Resources
Sponsored White Papers
Nurse scheduling is no longer just an operational task, it's a strategic lever for improving staff satisfaction, reducing burnout, and building a…
Other Resources
AACN has partnered with the American Organization for Nursing Leadership (AONL) to announce the release of a new playbook to guide academic and…
Sponsored White Papers
While 74% of hospital leaders believe virtual care will play an important role in care delivery, most hospitals remain in the early stages of…
Other Resources
h2{
margin-top: 0px;
}
p.center_Intro {
color: #002855;
line-height: 1.2em;
font-size: 30px;
margin: 10px
Other Resources
The American Organization for Nursing Leadership (AONL) and its Workforce Committee are leading a national effort to unde stand and address nurse…
Sponsored White Papers
The Evolv whitepaper, "The Impact of Workplace Violence on Nurses, Staff, Visitors, and Patients in Healthcare Facilities," offers an in-depth…